Beasley Allen has filed an opioid lawsuit against drug manufacturers and distributors on behalf of the City of Greensboro, Alabama, alleging the marketing of these drugs contributed to the creation of the opioid epidemic, a public health and safety crisis. Responding to the opioid crisis has required the City of Greensboro to sustain economic damages and to continue to bear a significant financial burden. The City of Greensboro is represented by Beasley Allen lawyers Rhon E. Jones, who is head of the firm’s Toxic Torts Section, Rick Stratton, Will Sutton, Ryan Kral and LaBarron Boone, along with attorneys William M. Pompey and Brenda M. Pompey of Pompey & Pompey law firm in Camden, Alabama.
Beasley Allen has filed similar lawsuits on behalf of a number of Alabama municipalities, as well as Sumner County, Tennessee. The firm also is representing the State of Alabama in its opioid lawsuit against Purdue Pharmaceuticals.
“The pharmaceutical industry lied to the American public when it flooded the market with highly addictive opioids,” said Jones. “The industry’s unrestrained greed created an opioid epidemic that continues to unfold across the nation. Local resources have been stretched beyond many municipalities’ limits, costing them a total of $504 billion dollars annually as they fight the complex and multifaceted problems that accompany opioid addiction.”
“The City of Greensboro has been held in opioid’s tight grip, draining local resources all because of the pharmaceutical industry’s greed,” William Pompey said. “It is time these drugmakers pay for ripping apart families and communities and putting the financial burden on the backs of hard-working taxpayers.”
“It is unconscionable that Big Pharma companies have created this public health crisis and then simply walked away from the mess,” Brenda Pompey said. “They are leaving communities like the City of Greensboro holding the bag, struggling to provide critical services for its citizens in the wake of the epidemic the drug companies created.”
Economic damages resulting from the opioid epidemic include costs for providing medical care, therapeutic care and treatments for patients suffering from opioid-related addiction or disease, including overdoses and deaths; costs for providing counseling and rehabilitation services; costs for treating infants born with opioid-related medical conditions; public safety and law enforcement expenses; and care for children whose parents suffer from opioid-related disability or incapacitation.
In 2016, Hale County, in which the City of Greensboro is located, had an opioid prescription rate of 97.7 for every 100 people. Nationally, opioids are responsible for killing more than 183,000 people since 1999, according to the Centers for Disease Control and Prevention (CDC). In 2016 alone, 42,000 people in the U.S. died from opioid overdoses.
Defendants include Purdue Pharma L.P.; Purdue Pharma, Inc.; The Purdue Frederick Company, Inc.; Teva Pharmaceutical Industries, LTD.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; Janssen Pharmaceutical Inc. n/k/a Janssen Pharmaceuticals, Inc.; Noramco, Inc.; Endo Health Solutions Inc.; Endo Pharmaceuticals, Inc.; Allergan PLC f/k/a Actavis PLS; Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc.; Watson Laboratories, Inc.; Actavis, LLC; Actavis Pharm a, Inc. f/k/a Watson Pharma, Inc.; Mallinckrodt plc; Mallinckrodt LLC; McKesson Corporation; Cardinal Health, Inc.; and AmerisourceBergen Drug Corporation.
The complaint is filed in the U.S. District Court for the Southern District of Alabama, Northern Division.